2020 JUL 06 (NewsRx) -- By a
Funders for this research include Fondation Alzheimer, LABEX (excellence laboratory, program investment for the future) DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer’s disease), university
The news correspondents obtained a quote from the research from
According to the news reporters, the research concluded: “Our data indicate that TFEB activation is a relevant strategy to prevent the accumulation of this early neurotoxic catabolite.”
For more information on this research see: The Transcription Factor Eb Reduces the Intraneuronal Accumulation of the Beta-secretase-derived App Fragment C99 In Cellular and Mouse Alzheimer’s Disease Models. Cells, 2020;9(5):1204. Cells can be contacted at: Mdpi, St Alban-Anlage 66, Ch-4052
Our news journalists report that additional information may be obtained by contacting F. Checler,
The direct object identifier (DOI) for that additional information is: https://doi.org/10.3390/cells9051204. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.
(Our reports deliver fact-based news of research and discoveries from around the world.)